Lista de obras -

A 5-year follow-up to evaluate the efficacy and safety of ofatumumab added to fludarabine and cyclophosphamide in patients with relapsed chronic lymphocytic leukemia: final analysis of the COMPLEMENT 2 trial

scientific article published on 28 February 2020

Allogeneic hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria - multicenter analysis by Polish Adult Leukemia Group

artículo científico publicado en 2020

Alterations of biomechanics in cancer and normal cells induced by doxorubicin

artículo científico publicado en 2017

Asymmetric and symmetric dimethylarginines and mortality in patients with hematological malignancies-A prospective study.

artículo científico publicado en 2018

Azacitidine in outpatient treatment - single center experience.

artículo científico publicado en 2016

Cereblon and IRF4 Variants Affect Risk and Response to Treatment in Multiple Myeloma.

scientific article published on 12 January 2017

Clinical response to azacitidine therapy depends on microRNA-29c (miR-29c) expression in older acute myeloid leukemia (AML) patients.

artículo científico publicado en 2016

Comparable Efficacy of Idelalisib Plus Rituximab and Ibrutinib in Relapsed/refractory Chronic Lymphocytic Leukemia: A Retrospective Case Matched Study of the Polish Adult Leukemia Group (PALG)

scientific article published on 01 May 2018

Comparing radioactive tracers 18F-FDG and 18F-FLT in the staging of diffuse large B-cell lymphoma by PET/CT examination: A single-center prospective study

artículo científico publicado en 2019

Concomitance of monosomal karyotype with at least 5 chromosomal abnormalities is associated with dismal treatment outcome of AML patients with complex karyotype - retrospective analysis of Polish Adult Leukemia Group (PALG).

artículo científico publicado en 2016

Efficacy and Safety of Bendamustine and Ibrutinib in Previously Untreated Patients With Chronic Lymphocytic Leukemia: Indirect Comparison

artículo científico publicado en 2017

Efficacy of high-dose corticosteroid-based treatment for chronic lymphocytic leukemia patients with p53 abnormalities in the era of B-cell receptor inhibitors

artículo científico publicado en 2020

Expression of microRNA-181 determines response to treatment with azacitidine and predicts survival in elderly patients with acute myeloid leukaemia

scientific article published on 08 August 2016

Expression of microRNA-331 can be used as a predictor for response to therapy and survival in acute myeloid leukemia patients.

artículo científico publicado en 2015

Gemcitabine-Based Treatment in Poor-Prognosis Patients with Relapsed and Refractory Hodgkin Lymphoma and Non-Hodgkin Lymphoma--a Multicenter Polish Experience

artículo científico publicado en 2015

Hematological malignancies in Polish population: what are the predictors of outcome in patients admitted to Intensive Care Unit?

artículo científico publicado en 2020

Higher efficacy of intermediate dose cytarabine + G-CSF compared to cyclophosphamide + G-CSF in hematopoietic stem cell mobilization in patients with multiple myeloma

scientific article published on 16 April 2020

Hodgkin lymphoma of the elderly patients: a retrospective multicenter analysis from the Polish Lymphoma Research Group

artículo científico publicado en 2018

Hodgkin lymphoma transformation of chronic lymphocytic leukemia-A real life data from the Polish Lymphoma Research Group.

artículo científico publicado en 2019

Immune Thrombocytopenia and JAK2V617F Positive Essential Thrombocythemia: Literature Review and Case Report

artículo científico publicado en 2017

Liposomal cytarabine in the prophylaxis and treatment of CNS lymphoma: toxicity analysis in a retrospective case series study conducted at Polish Lymphoma Research Group Centers

artículo científico publicado en 2015

Low expression of microRNA-204 (miR-204) is associated with poor clinical outcome of acute myeloid leukemia (AML) patients.

artículo científico publicado en 2015

Lymphocyte subsets in haematological patients with COVID-19: Multicentre prospective study

scientific article published on 11 November 2020

Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission

artículo científico publicado en 2020

Polish experience of lenalidomide in the treatment of lower risk myelodysplastic syndrome with isolated del(5q).

artículo científico publicado en 2015

Polymorphisms within beta-catenin encoding gene affect multiple myeloma development and treatment.

artículo científico publicado en 2015

Response to the Therapy in Hairy Cell Leukemia: Systematic Review and Meta-Analysis

artículo científico publicado en 2018

Rituximab, cladribine and cyclophosphamide (RCC) induction with rituximab maintenance in chronic lymphocytic leukemia: PALG - CLL4 (ML21283) trial.

artículo científico publicado en 2018

Serum NMR metabolomics to differentiate haematologic malignancies.

artículo científico publicado en 2018

Significance of OCT1 Expression in Acute Myeloid Leukemia.

artículo científico publicado en 2016

The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia.

artículo científico publicado en 2016

The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study.

artículo científico publicado en 2016

The comparison of effectiveness and safety between different biosimilars of G-CSF in the mobilization of peripheral blood stem cells (PBSCs) for autologous transplantation (autologous peripheral blood stem cell transplantation, auto-PBSCT)

artículo científico publicado en 2019

The expression of Toll-like receptors and development of severe sepsis in patients with acute myeloid leukemias after induction chemotherapy

artículo científico publicado en 2014

The expression of Toll-like receptors in patients with acute myeloid leukemia treated with induction chemotherapy.

artículo científico publicado en 2015

The role of soluble HLA-G and HLA-G receptors in patients with hematological malignancies after allogeneic stem cell transplantation

artículo científico publicado en 2015

bFGF Polymorphism Is Associated with Disease Progression and Response to Chemotherapy in Multiple Myeloma Patients.

artículo científico publicado en 2017

Lista de obras de

A 5-year follow-up to evaluate the efficacy and safety of ofatumumab added to fludarabine and cyclophosphamide in patients with relapsed chronic lymphocytic leukemia: final analysis of the COMPLEMENT 2 trial

Allogeneic hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria - multicenter analysis by Polish Adult Leukemia Group

Alterations of biomechanics in cancer and normal cells induced by doxorubicin

Asymmetric and symmetric dimethylarginines and mortality in patients with hematological malignancies-A prospective study.

Azacitidine in outpatient treatment - single center experience.

Cereblon and IRF4 Variants Affect Risk and Response to Treatment in Multiple Myeloma.

Clinical response to azacitidine therapy depends on microRNA-29c (miR-29c) expression in older acute myeloid leukemia (AML) patients.

Comparable Efficacy of Idelalisib Plus Rituximab and Ibrutinib in Relapsed/refractory Chronic Lymphocytic Leukemia: A Retrospective Case Matched Study of the Polish Adult Leukemia Group (PALG)

Comparing radioactive tracers 18F-FDG and 18F-FLT in the staging of diffuse large B-cell lymphoma by PET/CT examination: A single-center prospective study

Concomitance of monosomal karyotype with at least 5 chromosomal abnormalities is associated with dismal treatment outcome of AML patients with complex karyotype - retrospective analysis of Polish Adult Leukemia Group (PALG).

Efficacy and Safety of Bendamustine and Ibrutinib in Previously Untreated Patients With Chronic Lymphocytic Leukemia: Indirect Comparison

Efficacy of high-dose corticosteroid-based treatment for chronic lymphocytic leukemia patients with p53 abnormalities in the era of B-cell receptor inhibitors

Expression of microRNA-181 determines response to treatment with azacitidine and predicts survival in elderly patients with acute myeloid leukaemia

Expression of microRNA-331 can be used as a predictor for response to therapy and survival in acute myeloid leukemia patients.

Gemcitabine-Based Treatment in Poor-Prognosis Patients with Relapsed and Refractory Hodgkin Lymphoma and Non-Hodgkin Lymphoma--a Multicenter Polish Experience

Hematological malignancies in Polish population: what are the predictors of outcome in patients admitted to Intensive Care Unit?

Higher efficacy of intermediate dose cytarabine + G-CSF compared to cyclophosphamide + G-CSF in hematopoietic stem cell mobilization in patients with multiple myeloma

Hodgkin lymphoma of the elderly patients: a retrospective multicenter analysis from the Polish Lymphoma Research Group

Hodgkin lymphoma transformation of chronic lymphocytic leukemia-A real life data from the Polish Lymphoma Research Group.

Immune Thrombocytopenia and JAK2V617F Positive Essential Thrombocythemia: Literature Review and Case Report

Liposomal cytarabine in the prophylaxis and treatment of CNS lymphoma: toxicity analysis in a retrospective case series study conducted at Polish Lymphoma Research Group Centers

Low expression of microRNA-204 (miR-204) is associated with poor clinical outcome of acute myeloid leukemia (AML) patients.

Lymphocyte subsets in haematological patients with COVID-19: Multicentre prospective study

Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission

Polish experience of lenalidomide in the treatment of lower risk myelodysplastic syndrome with isolated del(5q).

Polymorphisms within beta-catenin encoding gene affect multiple myeloma development and treatment.

Response to the Therapy in Hairy Cell Leukemia: Systematic Review and Meta-Analysis

Rituximab, cladribine and cyclophosphamide (RCC) induction with rituximab maintenance in chronic lymphocytic leukemia: PALG - CLL4 (ML21283) trial.

Serum NMR metabolomics to differentiate haematologic malignancies.

Significance of OCT1 Expression in Acute Myeloid Leukemia.

The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia.

The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study.

The comparison of effectiveness and safety between different biosimilars of G-CSF in the mobilization of peripheral blood stem cells (PBSCs) for autologous transplantation (autologous peripheral blood stem cell transplantation, auto-PBSCT)

The expression of Toll-like receptors and development of severe sepsis in patients with acute myeloid leukemias after induction chemotherapy

The expression of Toll-like receptors in patients with acute myeloid leukemia treated with induction chemotherapy.

The role of soluble HLA-G and HLA-G receptors in patients with hematological malignancies after allogeneic stem cell transplantation

bFGF Polymorphism Is Associated with Disease Progression and Response to Chemotherapy in Multiple Myeloma Patients.